
Hosted by ProMIS Neurosciences · EN

This episode is a recording of the White Paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee, read by Shanti Skiffington.

This week Shanti and Eliot talk to Dr. Scott Napper, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, about the future of an Alzheimer’s Vaccine.

On today's episode, Shanti and Eliot talk to Dr. Neil Cashman about a vaccine for Alzheimer’s disease and how that fits into the detection, treatment, and prevention of the disease.

Shanti and Eliot talk to Dr. Josè Luis Molinuevo of the BarcelonaBeta Brain Research Center about his experience at AAIC, and the presentation he gave on biomarkers.

This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.

Episode Notes Shanti and Elliot talk to Dr. James Kupiec about a diagnostics test for Alzheimer's disease.

Episode Notes Shanti and Elliot discuss recent developments in antibody testing for Covid-19

Elliot and Shanti talk to Johanne Kaplan about a new way to attack ALS and other protein misfolding diseases,

This week Shanti and Elliot discuss Intrabodies with Dr. Johanne Kaplan

Dr. Jim Kupiec explains why there is nothing to worry about regarding the recent news about aducanumab.